Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      UK/Our innovation /Focus areas /Immunology

      Immunology

      slide-images/emea_immunology_research.jpg
      Our focus in immunology
      Johnson & Johnson Innovative Medicine (J&J) understands how distressing and debilitating immune-mediated inflammatory diseases can be, which is why we innovate with purpose to lead where medicine is going.

      Our goal is to improve diagnosis, patients’ access to the best possible treatments and continue to provide new and better medicines.
      Our immunology legacy
      Throughout J&J’s 30-year UK legacy in immunology, we have applied our deep disease and patient insights to deliver transformational treatments for patients with immune-mediated diseases.

      We continue to pioneer therapeutic advances and work closely with healthcare practitioners to help shape the management of immunological conditions.

      We have demonstrated our UK commitment to immunology over the past five years through:1
      135
      Medical education meetings
      40
      Grants and donations
      28
      Clinical publications
      885
      Patients enrolled in clinical trials
      Our treatment areas
      We are proud to offer one of the strongest treatment portfolios for some of the most common immune-mediated inflammatory diseases. Our focus areas include:
      JJ_BodyIllustration_Exterior_FemaleLowerFaceProfile_Colorway01.jpg
      Dermatology
      Psoriasis, a chronic disease affecting the skin for which there is no cure.2
      JJ_BodyIllustration_Exterior_KneePain_Colorway02.jpg
      Rheumatology
      Psoriatic arthritis, inflammation affecting the joints, tendons or ligaments, and rheumatoid arthritis.
      JJ_BodyIllustration_Interior_Organ_Colon_Colorway01.jpg
      Gastroenterology
      Inflammatory bowel disease, encompassing Crohn’s disease, a chronic condition affecting any region of the gastrointestinal tract, and ulcerative colitis, chronic inflammation of the large colon.3
      We understand how debilitating immune-mediated diseases can be for patients, which is why our team is focused each day on restoring health for patients living with these diseases. We strive to redefine the treatment landscape in the UK by delivering transformational and accessible therapies aimed at durable, symptom free remission.”
      Naomi Cragg
      Business Unit Director, Immunology, J&J Innovative Medicine UK
      Pioneering breakthroughs that change lives
      We’ve always been innovative in our science, finding new and effective ways to transform the course of immune-mediated inflammatory diseases. We continue to advance our understanding of the inflammatory process, working on improved therapies where the impact on patients is high and where there remains a need for better treatments.
      JJ_Photo_Lab tech inspecting substance in bottle_IM_1Star.jpg
      How we work
      Partner with us
      We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine
      October 7, 2024
      Reach out

      References

      1: Internal reports from 2019 – 2024.
      2: Psoriasis Association. About Psoriasis. Available at https://www.psoriasis-association.org.uk/treatments-for-psoriasis. Accessed 27 September 2024.
      3: Crohn’s & Colitis UK. All about Crohn’s and Colitis, Available at https://crohnsandcolitis.org.uk/info-support/information-about-crohns-and-colitis/all-information-about-crohns-and-colitis/understanding-crohns-and-colitis/all-about-crohns-and-colitis. Accessed 27 September 2024.

      CP-486603 | November 2024